Mersana Therapeutics Announces Initiation of the UPGRADE Phase 1 Platinum Combination Cohort for UpRi in Platinum-Sensitive Ovarian Cancer

July 28, 2021
12:00 pm

Mersana Therapeutics Announces Initiation of the UPGRADE Phase 1 Platinum Combination Cohort for UpRi in Platinum-Sensitive Ovarian Cancer

UPGRADE umbrella study designed to evaluate UpRi in combination with other therapies, starting with carboplatin
CAMBRIDGE, Mass., July 28, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused…

Click here to view the original article.

Global, Yahoo Entertainment

Share this article

Another bad year – and decade – for fossil fuel stocks

March 3, 2026

Ethereum Based Crypto Pepeto Announces $7,44M Raised While XRP Price Prediction Targets $20

March 3, 2026

Stock Price Forecasting by a Deep Convolutional Generative Adversarial Network

March 3, 2026

When crypto boom goes bust

March 3, 2026

Global travel stocks take a backseat

March 3, 2026

What is a Crypto Bull Run? Meaning, signs, and how to prepare

March 2, 2026

Ripple token bounces as DTCC listing and Iran war headlines steer crypto traders

March 2, 2026

3 Crypto To Watch Amid The US-Israel Iran War

March 2, 2026